Omeros Corporation (OMER) Stock Grade

About Omeros Corporation's fundamentals

Omeros Corporation is a biotechnology company with a market capitalization of $1.1 billion and a P/E ratio of 10.6, though this metric is notably influenced by the company's reported net loss in its latest annual statement. Revenue growth has stalled at 0.0% year-over-year, and the company is not currently profitable, reflected in a net margin of 0.0%. Return on equity stands at 2.8%, indicating minimal shareholder value generation from retained earnings, and the company does not pay a dividend. These metrics suggest the company is in a development or transition phase without current profitability or revenue expansion.